Putnam Investments Has Trimmed Procter & Gamble Co/The (PG) Stake By $2.73 Million; Mcclain Value Management Lowered Its Enanta Pharmaceuticals (ENTA) Stake

January 17, 2018 - By Adrian Mccoy

Mcclain Value Management Llc decreased Enanta Pharmaceuticals Inc (ENTA) stake by 41.71% reported in 2017Q3 SEC filing. Mcclain Value Management Llc sold 27,233 shares as Enanta Pharmaceuticals Inc (ENTA)’s stock rose 11.35%. The Mcclain Value Management Llc holds 38,062 shares with $1.78 million value, down from 65,295 last quarter. Enanta Pharmaceuticals Inc now has $1.26B valuation. The stock increased 4.81% or $3.02 during the last trading session, reaching $65.78. About 213,404 shares traded or 17.72% up from the average. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has risen 40.91% since January 17, 2017 and is uptrending. It has outperformed by 24.21% the S&P500.

Putnam Investments Llc decreased Procter & Gamble Co/The (PG) stake by 12.76% reported in 2017Q3 SEC filing. Putnam Investments Llc sold 30,375 shares as Procter & Gamble Co/The (PG)’s stock declined 5.32%. The Putnam Investments Llc holds 207,721 shares with $18.90M value, down from 238,096 last quarter. Procter & Gamble Co/The now has $231.37B valuation. The stock increased 1.09% or $0.98 during the last trading session, reaching $91.2. About 8.33 million shares traded or 22.42% up from the average. The Procter & Gamble Company (NYSE:PG) has risen 7.54% since January 17, 2017 and is uptrending. It has underperformed by 9.16% the S&P500.

Investors sentiment decreased to 0.82 in 2017 Q3. Its down 0.12, from 0.94 in 2017Q2. It dived, as 51 investors sold PG shares while 765 reduced holdings. 110 funds opened positions while 558 raised stakes. 1.50 billion shares or 1.10% more from 1.48 billion shares in 2017Q2 were reported. Fort Point Prns Limited Liability Company has 0.16% invested in The Procter & Gamble Company (NYSE:PG). Spectrum Asset Mngmt (Nb Ca) has invested 0.23% in The Procter & Gamble Company (NYSE:PG). Cramer Rosenthal Mcglynn Ltd Liability Corp has invested 0.01% of its portfolio in The Procter & Gamble Company (NYSE:PG). Parsec reported 109,053 shares stake. Arrow Fincl Corporation holds 1.15% or 53,300 shares in its portfolio. Covington Mngmt stated it has 1.17% of its portfolio in The Procter & Gamble Company (NYSE:PG). Duncker Streett Co Incorporated, Missouri-based fund reported 53,490 shares. Jacobs And Ca stated it has 1.15% in The Procter & Gamble Company (NYSE:PG). Ghp Invest Advisors has invested 0.8% of its portfolio in The Procter & Gamble Company (NYSE:PG). Peregrine Asset Advisers holds 0.15% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 3,162 shares. Alliancebernstein Limited Partnership has invested 0.65% in The Procter & Gamble Company (NYSE:PG). Winslow Evans Crocker Incorporated holds 16,162 shares. National Bank Of Ny Mellon invested in 0.75% or 29.90 million shares. Baker Ellis Asset Mngmt Lc has invested 0.33% in The Procter & Gamble Company (NYSE:PG). Scott & Selber holds 2,700 shares or 0.14% of its portfolio.

Among 24 analysts covering Proctor & Gamble (NYSE:PG), 12 have Buy rating, 0 Sell and 12 Hold. Therefore 50% are positive. Proctor & Gamble had 74 analyst reports since August 4, 2015 according to SRatingsIntel. Zacks downgraded the shares of PG in report on Tuesday, August 4 to “Hold” rating. The firm has “Hold” rating by SunTrust given on Thursday, October 5. The firm earned “Buy” rating on Wednesday, November 15 by Jefferies. On Tuesday, October 24 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. B. Riley & Co maintained The Procter & Gamble Company (NYSE:PG) rating on Wednesday, October 26. B. Riley & Co has “Buy” rating and $106 target. Jefferies maintained The Procter & Gamble Company (NYSE:PG) on Tuesday, May 30 with “Buy” rating. The firm earned “Sell” rating on Monday, January 9 by Goldman Sachs. The company was downgraded on Thursday, December 22 by Suntrust Robinson. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Thursday, July 14 by UBS. The stock has “Sell” rating by Pritchard Capital on Wednesday, August 19.

Putnam Investments Llc increased Williams Cos Inc (NYSE:WMB) stake by 19,895 shares to 990,420 valued at $29.72M in 2017Q3. It also upped Oshkosh Corp (NYSE:OSK) stake by 23,847 shares and now owns 184,298 shares. Cable One Inc was raised too.

Analysts await The Procter & Gamble Company (NYSE:PG) to report earnings on January, 19. They expect $1.14 EPS, up 5.56% or $0.06 from last year’s $1.08 per share. PG’s profit will be $2.89 billion for 20.00 P/E if the $1.14 EPS becomes a reality. After $1.09 actual EPS reported by The Procter & Gamble Company for the previous quarter, Wall Street now forecasts 4.59% EPS growth.

Since August 15, 2017, it had 0 buys, and 19 selling transactions for $6.75 million activity. 2,170 shares were sold by Schomburger Jeffrey K, worth $199,728 on Tuesday, August 15. Shares for $339,077 were sold by Pritchard Marc S.. Matthew Price sold $115,695 worth of stock. 2,512 The Procter & Gamble Company (NYSE:PG) shares with value of $231,206 were sold by Majoras Deborah P. The insider Abdelfattah Mohamed Samir Abdelrazek sold $77,130. 6,382 shares valued at $587,402 were sold by Taylor David S on Tuesday, August 15. Moeller Jon R sold $558,042 worth of stock.

Among 5 analysts covering Enanta Pharmaceuticals Inc (NASDAQ:ENTA), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Enanta Pharmaceuticals Inc had 20 analyst reports since August 7, 2015 according to SRatingsIntel. Barclays Capital downgraded it to “Underweight” rating and $16 target in Friday, October 23 report. On Tuesday, January 2 the stock rating was downgraded by RBC Capital Markets to “Sector Perform”. The rating was upgraded by JMP Securities on Tuesday, July 11 to “Market Outperform”. RBC Capital Markets maintained the stock with “Buy” rating in Monday, November 20 report. The rating was maintained by Robert W. Baird on Tuesday, August 8 with “Neutral”. The company was upgraded on Friday, October 23 by JMP Securities. The firm earned “Hold” rating on Monday, November 20 by Robert W. Baird. The rating was maintained by JP Morgan on Tuesday, August 9 with “Overweight”. The stock of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) earned “Hold” rating by Robert W. Baird on Friday, October 20. On Friday, August 7 the stock rating was downgraded by Zacks to “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: